Evaluating the Effectiveness of Paclitaxel-eluting Balloons for Below-the-knee Angioplasty in Patients With Critical Limb Ischemia
- Conditions
- Critical Limb Ischemia
- Registration Number
- NCT01938872
- Lead Sponsor
- Ospedale San Donato
- Brief Summary
to evaluate the the effectiveness of paclitaxel-eluting balloon for below-the-knee angioplasty in terms of restenosis at 12 months
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- UNKNOWN
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
- age>18 years
- angiographic stenosis>50% or occlusion of one below-knee vessel
Exclusion Criteria
- allergy to Paclitaxel
- contraindication for combined antiplatelet treatment
- life expectancy <1 year
- hypersensitivity or contraindication to one of the study drugs
- lack of consent
- need for amputation
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method angiographic binary restenosis 12 months incidence of binary restenosis
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie paclitaxel's anti-restenotic effects in below-the-knee angioplasty for CLI?
How does paclitaxel-eluting balloon angioplasty compare to drug-coated stents in treating critical limb ischemia?
What biomarkers are associated with improved patency outcomes after paclitaxel-eluting balloon therapy for BTK lesions?
What are the long-term safety concerns with paclitaxel-based interventions in peripheral artery disease patients?
Are there combination therapies showing enhanced efficacy with paclitaxel-eluting balloons for CLI treatment?
Trial Locations
- Locations (1)
Cardiovascular Department, Ospedale S.Donato
🇮🇹Arezzo, AR, Italy
Cardiovascular Department, Ospedale S.Donato🇮🇹Arezzo, AR, Italy